WO2008122099A1 - Composition for promoting sleep and relaxation comprising lemon balm - Google Patents
Composition for promoting sleep and relaxation comprising lemon balm Download PDFInfo
- Publication number
- WO2008122099A1 WO2008122099A1 PCT/CA2007/000575 CA2007000575W WO2008122099A1 WO 2008122099 A1 WO2008122099 A1 WO 2008122099A1 CA 2007000575 W CA2007000575 W CA 2007000575W WO 2008122099 A1 WO2008122099 A1 WO 2008122099A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- sleep
- individual
- effective amount
- relaxation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Abstract
A method for promoting restful, quality sleep in an individual comprising the administration of a composition comprising Lemon balm extract and one or more of Mesua ferrea plant powder, a source of reserpine, Catnip powder and Jamaica dogwood for the promotion of a feeling of relaxation conducive to the induction of sleep in an individual.
Description
Composition for promoting sleep and relaxation comprising Lemon balm
Field of the Invention
[001] The present invention is directed towards supplemental compositions and methods for promoting restful sleep in an individual by producing a feeling of relaxation.
Background of the Invention
[002] Sleep occupies about one-third of our life and is necessary for mental and physical well-being. It additionally affects mood, behavior and physiology. Sleep and the control of sleep is a complex process involving multiple neuro-chemical pathways and associated brain structures. It is a dynamic process involving a shift in the balance of distinct physiological changes, involving both positive and negative signaling neural signaling. The regulation of sleep in humans is governed by three processes - each influenced by hormonal and environmental factors: a daily sleep- wake cycle influenced by a circadian rhythm (24 hour cycle) tied to light-dark cycles.
[003] The need for sleep is a biological drive similar to thirst or hunger.
Interestingly though, the function of sleep is largely unknown, however some evidence indicates that sleep is required for learning. In North America, insomnia is estimated to affect a significant portion of the population every year and is associated with health problems and concomitant economic loss to society (Stoller MK. Economic effects of insomnia. Clin Ther. 1994 Sep-Oct;16(5):873-97 Abstract). It is clear that the impairment of sleep is detrimental to one's health, hi humans, mild sleep deprivation results in indications of impaired immune system function (Irwin M, McClintick J, Costlow C, Former M, White J, Gillin JC. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996 Apr;10(5):643-53). Prolonged sleep deprivation is even known to result in death. It has been determined by many that an individual can survive longer without food than one can without sleep; thus indicating the importance of sleep.
[004] Strategies to improve sleep are beneficial, not only in terms of one's physical health, but also in terms of emotional health. Furthermore, reinforcement of sleep of adequate quantity and quality positively impacts most aspect of daily life.
Summary of the Invention
[005] The foregoing needs and other needs and objectives that will become apparent for the following description are achieved in the present invention, which comprises an extract of Lemon balm and one at least one of Mesua ferrea plant powder, a source of reserpine, Catnip powder and Jamaica dogwood for the promotion of restful sleep in an individual by producing a feeling of relaxation and a feeling of a reduction in stress conducive to the promotion of sleep.
Detailed Description of the Invention
[006) m tne following description, for the purposes of explanations, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It will be apparent, however, to one of ordinary skill in the art that the present invention may be practiced without these specific details.
[007] The present invention is directed towards a composition for promoting relaxation and a feeling of a reduction in stress in an individual comprising and extract of Lemon balm and at least one of Mesua ferrea plant powder, a source of reserpine, Catnip powder and Jamaica dogwood. A method for promoting a restful period of sleep via the promotion of relaxation and a feeling of a reduction in stress is also provided by present invention comprising the step of administration of a composition of the present invention, to an individual, said composition comprising an extract of Lemon balm and at least one of Mesua ferrea plant powder, a source of reseipine, Catnip powder and Jamaica dogwood.
[008] Incorporated herein by reference are the specifications of co-pending applications (filed contemporaneously with the present application) entitled "Composition for a Feeling of Calmness" and "Composition for Supporting Restful Sleep".
[009] The term 'sleep' for the purposes of the present invention is defined as a natural or artificially induced state of suspension of sensory and motor activity in an individual.
[0010] It is herein understood that improvements in sleep may be both of a quantitative nature e.g. an increase in the length of sleep, a decreased time in the time of sleep onset, and of a qualitative nature e.g. a deeper, more restful undisturbed period of sleep. It is further understood that improvement in sleep may also be both
direct and indirect. For example, sleep will be directly improved by the administration of a substance which is known to reduce time to sleep onset. Sleep may be indirectly improved, for example, by the administration of a substance which is known to result in feelings of relaxation and calmness. It is an aspect of the present invention to provide an individual consuming a composition of the present invention herein disclosed with an induced feeling of relaxation and a feeling of a reduction in stress leading to a more restful sleep.
Lemon Balm extract
[0011] Lemon balm {Melissa officinalis) is a member of the mint family and often referred to a 'the calming herb'. Lemon balm extract has antioxidant activity which likely contributes to its beneficial effects. However, it also displays central nervous system acetylcholine receptor activity, suggesting another possible activity mechanism in the body of an individual relating to relaxation.
[0012] Randomized, placebo-controlled, double-blind clinical studies investigating the acute effects of Lemon balm extract on cognition and mood demonstrated a calming effect (Kennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003 Oct;28(10):1871-81). Lemon balm extract has shown potential at reducing the negative mood effects of stress in clinical trials (Kennedy DO, Little W, Scholey AB. Attenuation of laboratory- induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. 2004 Jul-Aug;66(4):607-13). [0013] In an embodiment of the present invention which is set forth in greater detail in the example below, the composition comprises Lemon balm extract to promote calmness and improved mood resulting in a feeling of relaxation. A serving of the supplemental composition includes from about 0.010 g to about 1.000 g of Lemon balm extract. The preferred dosage of Lemon balm extract in the present invention comprises about 0.240 g. per serving.
Mesua ferrea
[0014] Mesua ferrea, from the family Clusiaceae, is a medium- to large evergreen tree used in traditional medicine. Xanthones from the plant have demonstrated central nervous system activities such as sedation and decreased spontaneous motor activity in rats and mice (Gopalakrishnan,C, Shankaranarayanan,
D., Nazimudeen, S.K., Viswanathan, S., Kameswaran, L., Anti-inflammatory and
C.N.S. Depressant activities of xanthones from Calophyllum inophyllum and Mesua
Ferrea. Indian Journal of Pharmacology, 12 (3) 181-191, 1980 Abstract). It is herein understood by the inventors that the administration of Mesua ferrea would be beneficial to induce relaxation in an individual.
[0015] In an embodiment of the present invention which is set forth in greater detail in the example below, the composition includes Mesua ferrea plant powder to produce mild sedative effects conducive to a feeling of relaxation. A serving of the supplemental composition comprises from about 0.0001 g to about 0.0100 g of Mesua ferrea plant powder. The preferred dosage of Mesua ferrea plant powder in the present invention comprises about 0.0020 g per serving.
Rauvolfia serpentine
[0016] Rauvolfia serpentine (also commonly known as Rauwolfia serpentine) is an evergreen grown mostly in tropical climates and has been used in traditional medicine for a number of potential benefits including reduction of blood pressure and hypnotic effects. Rauvolfia serpentine has long been used clinically in the treatment of mild-hypertension. The active ingredient, reserpine, acts by reducing specific neuro-chemical signaling molecules known as catecholamines (Isharwal S, Gupta S. Rustom JaI Vakil: his contributions to cardiology. Tex Heart Inst J. 2006;33(2):161- 70). A reduction in the amount of catecholamines, which are known to act as stimulants at sympathetic nerve endings, circulating in the body is herein understood by the inventors to aid the promotion of relaxation. Catecholamines, when acting upon their receptor are known to increase the heart rate and force of muscular contraction in the heart, constrict peripheral blood vessels, and elevate blood pressure. [0017] In an embodiment of the present invention which is set forth in greater detail in the example below, the composition comprises a source of reserpine to reduce excessive neuron-chemical signaling to produce hypotensive effects conducive
to a feeling of relaxation. A serving of the supplemental composition includes from about 0.0001 g to about 1.000 g of a source of reserpine.
Catnip Flower Powder
[0018] The genus Nepeta includes the herb Nepeta cataria, also known as catnip. Catnip is known to have sedative sleep enhancing effects in animals (Sherry CJ, Hunter PS. The effect of an ethanol extract of catnip (Nepeta cataria) on the behavior of the young chick. Experientia. 1979 Feb 15;35(2):237-8 Abstract; Massoco CO, Silva MR, Gorniak SL, Spinosa MS, Bernardi MM. Behavioral effects of acute and long-term administration of catnip (Nepeta cataria) in mice. Vet Hum Toxicol. 1995 Dec;37(6):530-3 Abstract). AS such, Catnip has long been used in humans as a sleep aid and evidence suggests such efficacy in humans, producing sedative effects by depressing the central nervous system (Osterhoudt KC, Lee SK, Callahan JM, Henretig FM. Catnip and the alteration of human consciousness. Vet Hum Toxicol. 1997 Dec;39(6):373-5 Abstract). [0019] In an embodiment of the present invention which is set forth in greater detail in the example below, the composition comprises Catnip powder to produce sedative effects to promote sleep. A serving of the supplemental composition comprises from about 0.0001 g to about 0.0100g of Catnip powder. The preferred dosage of Catnip powder in the present invention comprises about 0.0010 g per serving.
Piscidia piscipula
[0020] Piscidia piscipula (Jamaica dogwood) has traditional use as a treatment for insomnia and as a sedative (Mitchell SA, Ahmad MH. A review of medicinal plant research at the University of the West Indies, Jamaica, 1948-2001. West Indian Med J. 2006 Sep;55(4):243-69). It has been used specifically to induce sleep (The Eclectic Materia Medica, Pharmacology and Therapeutics av Harvey W. Felter, 1922, Monographs extracted by M. Moore. Pg 353).
[0021] In an embodiment of the present invention which is set forth in greater detail in the example below, the composition includes Jamaica dogwood to produce sedative effects to promote sleep. A serving of the supplemental composition includes from about 0.0001 g to about 0.0100 g of Jamaica dogwood. The preferred
dosage of Jamaica dogwood in the present invention comprises about 0.0010 g per serving.
[0022] In a preferred embodiment of the present invention, the composition comprises an extract of Lemon balm extract and at least one of Mesua ferrea plant powder, a source of reserpine, Catnip powder and Jamaica dogwood for the promotion of a restful period of sleep in an individual by producing a feeling of relaxation and a feeling of a reduction in stress. The promotion of a restful period of sleep is achieved in the present invention through the administration of said composition to an individual. The method of the present invention comprises at least the step of orally administering to an individual a therapeutically acceptable amount of the composition of the present invention.
[0023] Not wishing to be bound by theory, it is believed that the components of the present invention will act in concert through distinct mechanisms each having synergistic or additive effects to promote a restful period of sleep by encouraging a feeling of relaxation and a feeling of a reduction in stress.
[0024] According to various embodiments of the present invention, the nutritional supplement may be consumed in any form. For instance, the dosage form of the nutritional supplement may be provided as, e.g., a powder beverage mix, a liquid beverage, a ready-to-eat bar or drink product, a capsule, a liquid capsule, a tablet, a caplet, or as a dietary gel. The preferred dosage forms of the present invention are as a tablet or caplet.
[0025] In an embodiment of the present invention the composition may be provided in a solid dosage form with specific controlled-release characteristics. Advantageously, the composition may be provided in a layered solid dosage form. In such a form each individual layer will provide unique dissolution characteristics. In this way a controlled-release of the composition can be achieved. In one aspect of this embodiment, each layer may contain a homogeneous mixture of ingredients whereby the release of all ingredients is dependent upon the characteristics of layer to which the ingredients are included, hi an alternative aspect of this embodiment, each layer may contain a distinct set of specific ingredients which differ according to the layer such that different specific ingredients are released at different times. In all aspects of this embodiment, a temporally controlled-release of ingredients is achieved.
[0026] Furthermore, the dosage form of the nutritional supplement may be provided in accordance with customary processing techniques for herbal and nutritional supplements in any of the forms mentioned above. Additionally, the nutritional supplement set forth in the example embodiment herein may contain any appropriate number and type of excipients, as is well known in the art.
[0027] The present nutritional composition or those similarly envisioned by one of skill in the art may be utilized in methods to promote a restful period of sleep in an individual.
[0028] Advantageously, the present composition may be used not only as a sole means of promoting and supporting restful sleep but may also be used either in addition to other similarly-directed compositions or as a component of a larger composition.
[0029] Although the following example illustrates the practice of the present invention in one of its embodiments, the example should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one of skill in the art from consideration of the specifications and example.
Example
[0030] A nutritional supplement to help promote restful, quality sleep for use immediately prior to bedtime. A serving of the nutritional supplement as a caplet contains the following:
[0031] About 0.240 g of an extract of Lemon balm, about 0.002 g of Mesua ferrea plant powder,, about 0.001 g of Catnip powder and about 0.001 g of Jamaica dogwood.
Extensions and Alternatives [0032] In the foregoing specification, the invention has been described with a specific embodiment thereof, however, it will be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the invention.
Claims
1. A composition comprising an effective amount of an extract of Lemon balm and an effective amount of at least one ingredient selected from the group consisting of:
Mesuaferrea plant powder, a source of reserpine, Catnip powder and Jamaica dogwood.
2. The composition of claim 1 wherein the composition is provided in a therapeutically effective amount to synergistically produce a feeling of relaxation conducive to the promotion of sleep in an individual.
3. The composition of claim 1 wherein the composition is provided in a therapetually effective amount to synergistically produce a feeling of a reduction in stress conducive to the promotion of sleep in an individual.
4. A method comprising at the least step of administering to an individual a composition comprising an effective amount of an extract of Lemon balm and an effective amount of at least one ingredient selected from the group consisting of:
Mesua ferrea plant powder, a source of reserpine, Catnip powder and Jamaica dogwood wherein said composition is provided in a therapeutically effective amount to promote sleep in an individual.
5. The method of claim 4 wherein the administration of the therapeutically effective amount of the composition to the individual produces a feeling of relaxation conducive to the promotion of sleep in an individual.
6. The method of claim 4 wherein the administration of the therapeutically effective amount of the composition to the individual produces a feeling of a reduction in stress conducive to the promotion of sleep in an individual.
7. The composition of claim 1, wherein the composition is in a specifically controlled-release solid dosage form.
8. The method of claim 4, wherein the composition is in a specifically controlled-release solid dosage form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2007/000575 WO2008122099A1 (en) | 2007-04-05 | 2007-04-05 | Composition for promoting sleep and relaxation comprising lemon balm |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2007/000575 WO2008122099A1 (en) | 2007-04-05 | 2007-04-05 | Composition for promoting sleep and relaxation comprising lemon balm |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008122099A1 true WO2008122099A1 (en) | 2008-10-16 |
Family
ID=39830424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2007/000575 WO2008122099A1 (en) | 2007-04-05 | 2007-04-05 | Composition for promoting sleep and relaxation comprising lemon balm |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008122099A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949461A (en) * | 2012-10-25 | 2013-03-06 | 北京华夏众芳生物科技有限公司 | External traditional Chinese medicine composition and preparation for treating nodular type acnes and preparation method thereof |
WO2016044299A1 (en) * | 2014-09-15 | 2016-03-24 | Kemin Industries, Inc. | Plant extracts for improving cognitive function |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030013639A1 (en) * | 2001-07-03 | 2003-01-16 | Lisa Yurchak | Sleep inducing antacid composition |
US20040185014A1 (en) * | 2003-03-18 | 2004-09-23 | Arthur Zuckerman | Sleep inducing toothpaste made with natural herbs and a natural hormone |
-
2007
- 2007-04-05 WO PCT/CA2007/000575 patent/WO2008122099A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030013639A1 (en) * | 2001-07-03 | 2003-01-16 | Lisa Yurchak | Sleep inducing antacid composition |
US20040185014A1 (en) * | 2003-03-18 | 2004-09-23 | Arthur Zuckerman | Sleep inducing toothpaste made with natural herbs and a natural hormone |
Non-Patent Citations (3)
Title |
---|
HARNEY J.W. ET AL.: "Behavioral and toxicologcial studies of cyclopentanoid monoterpenes from Nepeta cataria", LLOYDIA, vol. 41, 1978, pages 367 - 374 * |
SHERRY C.J. AND HUNTER P.S.: "The effect of an ethanol extract of catnip on the behavior of the young chick", EXPERIENTIA, vol. 35, 1979, pages 237 - 238 * |
SOULIMANI R. ET AL.: "Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse", PLANTA MEDICA, vol. 57, 1991, pages 105 - 109 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949461A (en) * | 2012-10-25 | 2013-03-06 | 北京华夏众芳生物科技有限公司 | External traditional Chinese medicine composition and preparation for treating nodular type acnes and preparation method thereof |
WO2016044299A1 (en) * | 2014-09-15 | 2016-03-24 | Kemin Industries, Inc. | Plant extracts for improving cognitive function |
EP3194028A4 (en) * | 2014-09-15 | 2018-10-10 | Kemin Industries, Inc. | Plant extracts for improving cognitive function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carai et al. | Potential use of medicinal plants in the treatment of alcoholism | |
US20080248103A1 (en) | Melatonin-based composition for improved sleep | |
Borrás et al. | Medicinal plants for insomnia related to anxiety: an updated review | |
Alramadhan et al. | Dietary and botanical anxiolytics | |
Lanje et al. | Medicinal natural drug of Valerian (Valerina Officinalis): an-over review | |
CN1127902C (en) | Health-care tea for tranquilizing and improving sleep | |
Consolini et al. | Patterns of self-medication with medicinal plants and related adverse events-a South American survey | |
He et al. | Food plant extracts for sleep-related skin health: Mechanisms and prospects | |
US20080248141A1 (en) | Composition for a feeling of relaxation | |
WO2008122099A1 (en) | Composition for promoting sleep and relaxation comprising lemon balm | |
CN101541193A (en) | Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses | |
Abenavoli et al. | Phytotherapeutic approach to alcohol dependence: new old way? | |
Watson | Performance functional foods | |
Wei et al. | Headaches, migraine, and herbal medicine | |
JP2006213608A (en) | Antidepressant and use of the same | |
Bessette | Natural products and gynecology | |
US7374785B1 (en) | Composition for a feeling of calmness | |
Moyad et al. | Rapid review of breast cancer treatment side effects and dietary supplement/integrative options from A to Z: what helps, harms, or does nothing? | |
Herberger et al. | Somnologics: Medicines for the Treatment of Sleep Disorders | |
Eggleston et al. | Chocolate and Pain Tolerance | |
WO2008122102A1 (en) | Melatonin-based composition for improved sleep | |
Greenway et al. | Herbal and alternative approaches to obesity | |
Singh et al. | A STUDY TO EVALUATE THE EFFECT OF SWADAMSHTRADI RASAYANA IN THE MANAGEMENT OF NIDRANASHA | |
Ascani et al. | The Use of Psychotropic Herbal and Natural Medicines in Latina/o and Mestiza/o Populations | |
Naeem et al. | Exploring the Efficacy and Safety of Herbal Remedies for the Management of Sleep Deprivation in Insomnia: Herbal Remedies for the Management of Sleep Deprivation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07719505 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07719505 Country of ref document: EP Kind code of ref document: A1 |